Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience
Paediatrics
Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience
Paediatrics

Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience

J Nephrol. 2024 Aug 20. doi: 10.1007/s40620-024-02057-9. Online ahead of print.

NO ABSTRACT

PMID:39162952 | DOI:10.1007/s40620-024-02057-9